N-(2-(1-(3-ethoxy-4-methoxybenzyl)piperidin-4-ylamino)benzo[d]oxazol-5-yl)acetamide

ID: ALA1078283

PubChem CID: 46882621

Max Phase: Preclinical

Molecular Formula: C24H30N4O4

Molecular Weight: 438.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOc1cc(CN2CCC(Nc3nc4cc(NC(C)=O)ccc4o3)CC2)ccc1OC

Standard InChI:  InChI=1S/C24H30N4O4/c1-4-31-23-13-17(5-7-22(23)30-3)15-28-11-9-18(10-12-28)26-24-27-20-14-19(25-16(2)29)6-8-21(20)32-24/h5-8,13-14,18H,4,9-12,15H2,1-3H3,(H,25,29)(H,26,27)

Standard InChI Key:  XOEOXYIMADHJLD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   10.3669  -21.0347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3657  -21.8621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0829  -22.2749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0810  -20.6221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7943  -21.0308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7946  -21.8570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5811  -22.1101    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.0693  -21.4434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5799  -20.7778    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.8940  -21.4426    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3071  -22.1546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8957  -22.8710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3048  -23.5804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1300  -23.5843    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5440  -22.8717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1329  -22.1553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5401  -24.3026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3647  -24.3051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7721  -25.0176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5960  -25.0206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0115  -24.3089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5965  -23.5881    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7741  -23.5890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0083  -22.8755    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.8331  -22.8748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2449  -22.1576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8362  -24.3104    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.2474  -25.0234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6529  -22.2738    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9410  -21.8609    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2237  -22.2725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9417  -21.0361    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  6  7  1  0
 14 17  1  0
  7  8  2  0
 17 18  1  0
  8  9  1  0
 18 19  2  0
  9  5  1  0
 19 20  1  0
  4  1  1  0
 20 21  2  0
  8 10  1  0
 21 22  1  0
  5  6  1  0
 22 23  2  0
 23 18  1  0
 10 11  1  0
 22 24  1  0
 11 12  1  0
 24 25  1  0
 25 26  1  0
  2  3  1  0
 21 27  1  0
  3  6  2  0
 27 28  1  0
  1  2  2  0
  2 29  1  0
  5  4  2  0
 29 30  1  0
 11 16  1  0
 30 31  1  0
 12 13  1  0
 30 32  2  0
M  END

Associated Targets(Human)

SSTR5 Tclin Somatostatin receptor 5 (1477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR2 Tclin Somatostatin receptor 2 (1526 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR3 Tclin Somatostatin receptor 3 (1562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SSTR4 Tclin Somatostatin receptor 4 (1125 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 438.53Molecular Weight (Monoisotopic): 438.2267AlogP: 4.27#Rotatable Bonds: 8
Polar Surface Area: 88.86Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.70CX Basic pKa: 7.55CX LogP: 2.51CX LogD: 2.13
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.54Np Likeness Score: -1.51

References

1. Martin RE, Mohr P, Maerki HP, Guba W, Kuratli C, Gavelle O, Binggeli A, Bendels S, Alvarez-Sánchez R, Alker A, Polonchuk L, Christ AD..  (2009)  Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,  19  (21): [PMID:19786348] [10.1016/j.bmcl.2009.09.024]

Source